B I09, is a novel chromenone-based covalent inhibitors of IIRE-1 RNase. It Inhibits IRE-1/XBP1 pathway, and thus growth of human chronic lymphocytic leukemia (CLL) cells in vitro and promotes CLL regression in a mouse model. Molecular Formula: C16H17NO5
Molecular Weight:
303.31
CAS Number:
[1607803-67-7]
* VAT and and shipping costs not included. Errors and price changes excepted